Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Idrian García-García"'
Autor:
Orestes Santos-Morales, Alina Díaz-Machado, Daise Jiménez-Rodríguez, Yaisel Pomares-Iturralde, Tatiana Festary-Casanovas, Carlos A. González-Delgado, Sonia Pérez-Rodríguez, Eulalia Alfonso-Muñoz, Carmen Viada-González, Patricia Piedra-Sierra, Idrian García-García, Daniel Amaro-González, for the NeuroEPO Study Group, Julio César García-Rodríguez, Iliana Sosa-Testé, Alicia Lagarto-Parra, Laura Barrero-Viera, Marlene David-Baldo, Maura Tamayo-Rodríguez, Ivonne Rivero-Vázquez, Gricel González-Gamiz, Alis Martín-Trujillo, Yasmila Rodríguez-Fernández, Ana Alfa Ledo-de la Luz, Maylén Álvarez-Delgado, Ivón Howland-Álvarez, Yolanda Cruz-Gómez
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Delivery of therapeutic agents as erythropoietin (EPO) into Central Nervous System through intranasal route could benefit patients with neurological disorders. A new nasal formulation containing a non-hematopoietic recombinant EPO
Externí odkaz:
https://doaj.org/article/e517e2c5af464c38a783b22d08a467d6
Autor:
Magnelis Machado-Leiva, Daise Jiménez-Rodríguez, Tatiana Festary-Casanovas, Deydree C. Silveira-Pacheco, Emilio S. Barroso-de la Cruz, Mariela Suárez-Reyes, Genma Salas-Cruz, Haydee Wong-Arocha, Roberto Fernández-Viera, Ángela D. Tuero-Iglesias, René Delgado-Hernández, Idrian García-García, Calprost Study Group
Publikováno v:
Journal of Pharmacy & Pharmacognosy Research, Vol 4, Iss 5, Pp 187-198 (2016)
Context: Benign Prostatic Hyperplasia (BPH) is a common disease that course with Lower Urinary Tract Symptoms (LUTS), mainly in over 50 years-old men. Commonly indicated drugs such as alpha adrenergic-blockers are life-treatment with some adverse rea
Externí odkaz:
https://doaj.org/article/15c8421d6aed4950b00bd0814a5d25e8
Autor:
Daisy Bencomo-García, Lissette Cárdenas-de Baños, Niurka Hernández-Labrada, Jhossmar Cristians Auza Santivañez, Idrian García-García, Sergio González-García
Publikováno v:
Data & Metadata.
Introduction: The years 2020 and 2021 were characterized by the COVID-19 epidemic in Cuba, which led to the adaptation of academic courses with the premise of flexible learning processes, through the suspension of in-person activities and modificatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dacc1672230c58bdad94959d67977e39
https://doi.org/10.56294/dm202327
https://doi.org/10.56294/dm202327
Autor:
Roberto Rodriguez‐Labrada, Ricardo Ortega‐Sanchez, Patricia Hernández Casaña, Orestes Santos Morales, Maria del Carmen Padrón‐Estupiñan, Maricela Batista‐Nuñez, Daise Jiménez Rodríguez, Nalia Canales‐Ochoa, Arnoy Peña Acosta, Jacqueline Medrano Montero, Pedro Enrique Labrada Aguilera, Annelie Estupiñán Rodriguez, Yaimee Vazquez‐Mojena, Dennis Almaguer Gotay, Judey Aymed‐García, Idrian García‐García, Reydenis Torres Vega, Carmen Viada González, Carmen M. Valenzuela Silva, Yanelis Silva Ricardo, Jorge Columbié Ximelis, Kenia Tribin Rivero, Roselin Valle Cabrera, Julio Cesar García‐Rodriguez, Tania Crombet Ramos, Daniel Amaro‐González, Teresita Rodriguez‐Obaya, Luis Velázquez‐Pérez
Publikováno v:
Movement Disorders. 37:1516-1525
Several pieces of evidence have shown the neurotrophic effect of erythropoietin (EPO) and its introduction in the therapeutic practice of neurological diseases. However, its usefulness in the treatment of spinocerebellar ataxia type 2 (SCA2) has not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7b22b1c3c3fd79d6f1e9a399834eae
https://doi.org/10.1002/mds.29045
https://doi.org/10.1002/mds.29045
Autor:
Rosario Campos-Mojena, Alieski Cruz-Ramírez, Ángela D. Tuero-Iglesias, Iraldo Bello-Rivero, Alina Díaz-Machado, Sonia Pérez-Rodríguez, Pedro Lopez-Saura, Alis Martín-Trujillo, Ignacio Hernández-González, Carmen M Valenzuela-Silva, Hector Santana-Milian, Carlos A. González-Delgado, Idrian García-García, Yanelda García-Vega
Publikováno v:
BMC Pharmacology & Toxicology
More potent antitumor activity is desired in Interferon (IFN)-treated cancer patients. This could be achieved by combining IFN alpha and IFN gamma. The aim of this work was to characterize the pharmacokinetics and pharmacodynamics of a novel formulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::268afa09b3a2a1a743d3a901e6e22b39
https://doi.org/10.1186/s40360-016-0103-8
https://doi.org/10.1186/s40360-016-0103-8
Autor:
Daniel F. Alonso, Hilda Garay, Aley Palau, Silvio E. Perea, Arielis Rodriguez, Jorge L. Soriano, Aniel Sanchez, Margarita Solares, Hugo Sigman, Idania Baladrón, Idrian García García, Marisol Cruz, Lila Castellanos, Phillipe Perrin, Carmen Valenzuela, Ignacio Hernández, Roberto Gómez, Jean-Yves Renualt, Hernan G. Farina, M. López, Jeovanis Gil, Carlos Alonso González, Vladimir Besada, Daniel E. Gomez, Lazaro Betancourt, Luis Javier Herrera, Pedro Lopez-Saura, Alina Díaz, Yasser Perera, Adlin Lopez, A. E. G. Santana, N. Batista, Luis Javier González, Lidia González, Boris Acevedo, Osvaldo Reyes, Yanelda García
Publikováno v:
Molecular and Cellular Biochemistry. 356:45-50
CK2 represents an oncology target scientifically validated. However, clinical research with inhibitors of the CK2-mediated phosphorylation event is still insufficient to recognize it as a clinically validated target. CIGB-300, an investigational pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8d8256f42a9e3128596599158ae12d
https://doi.org/10.1007/s11010-011-0950-y
https://doi.org/10.1007/s11010-011-0950-y
Autor:
Elizeth Garcia Iglesias, Jorge V. Gavilondo, Milagros Velasco Mirabal, Idrian García García, Pedro López Saura, Gilmara Pimentel González, Carlos Calderón Marín, Ramón de Jesús Ropero Toirac, Adlin López Díaz, Rosalina López de Queralta, Lincidio Pérez Sánchez, Juan P Oliva González, Joaquín Jorge González González, Fausto L. García Ruiz, Marta Ayala Avila
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 26:353-363
Center for Genetic Engineering and Biotechnology (CIGB)-M3 is a trivalent recombinant single-chain Fv antibody fragment specific for carcinoembryonic antigen (CEA). Preclinical studies with radiolabeled CIGB-M3 have showed that the antibody fragment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c28d5c18cfd917e7beb2c2e0bccb3b6
https://doi.org/10.1089/cbr.2010.0899
https://doi.org/10.1089/cbr.2010.0899
Autor:
Sonia Collazo Caballero, Ena Infante Cristiá, Israel Alfonso-Trujillo, Acela P. Dopico Toledo, Hugo Nodarse Cuní, Idrian García García
Publikováno v:
Piel. 24:292-299
Introduccion El condiloma acuminado es una enfermedad viral caracterizada por lesiones verrugosas anogenitales, en la cual los procedimientos terapeuticos habituales son destructores de tejido. Hay evidencia de que el uso de interferon (IFN) es efect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2bea8a5d0b1bc36c2b3c7ec7793fcec
https://doi.org/10.1016/s0213-9251(09)71644-2
https://doi.org/10.1016/s0213-9251(09)71644-2
Autor:
Idrian García García, Boris Acevedo, Idania Baladrón, Y M González, M A Coca, M R Sarduy, Ignacio Hernández, Roberto Gómez, Yasser Perera, Luis Javier González, Vilcy Reyes, L. Torres, L Molina, Carmen Valenzuela, Y M Martínez, S E Perea-Rodríguez, A Prats, Daniel F. Alonso, J A Ancízar, A Perera, Margarita Solares, Pedro Lopez-Saura, C A Casacó
Publikováno v:
British Journal of Cancer
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Background:We conducted a phase 1 trial in patients with locally advanced cervical cancer by injecting 0.5 ml of the CK2-antagonist CIGB-300 in two different sites on tumours to assess tumour uptake, safety, pharmacodynamic activity and identify the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ff68d747863c7b215eb4d39d1ebc66
https://www.nature.com/articles/bjc2015137
https://www.nature.com/articles/bjc2015137
